Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Sales Revenue, Goods, Net (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

AIM IMMUNOTECH INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)

AIM IMMUNOTECH INC. (AIM) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $23.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-16.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SalesRevenueGoodsNet · last filed 2015-11-16

  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $23.00K, a 48.89% decline year-over-year.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2015-06-30 was $47.00K, a 30.56% increase year-over-year.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $36.00K, a 52.63% decline year-over-year.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $40.00K, a 11.11% increase year-over-year.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $197.00K, a 31.33% increase from fiscal 2013.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2013 was $150.00K, a 29.58% decline from fiscal 2012.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2012 was $213.00K, a 32.30% increase from fiscal 2011.
  • AIM IMMUNOTECH INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2011 was $161.00K, a 19.26% increase from fiscal 2010.
Period endSales Revenue, Goods, Net (Deprecated 2018-01-31) 3 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 6 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 9 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month
2015-09-30$23.00K
10-Q · filed 2015-11-16
$70.00K
derived: sum of 2 quarters · filed 2015-11-16
$106.00K
10-Q · filed 2015-11-16
$146.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-06-30$47.00K
10-Q · filed 2015-08-12
$83.00K
10-Q · filed 2015-08-12
$123.00K
derived: sum of 3 quarters · filed 2015-08-12
$168.00K
derived: sum of 4 quarters · filed 2015-11-16
2015-03-31$36.00K
10-Q · filed 2015-05-12
$76.00K
derived: sum of 2 quarters · filed 2015-05-12
$121.00K
derived: sum of 3 quarters · filed 2015-11-16
$157.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-12-31$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$85.00K
derived: sum of 2 quarters · filed 2015-11-16
$121.00K
derived: sum of 3 quarters · filed 2015-11-16
$197.00K
10-K · filed 2015-03-19
2014-09-30$45.00K
10-Q · filed 2015-11-16
$81.00K
derived: sum of 2 quarters · filed 2015-11-16
$157.00K
10-Q · filed 2015-11-16
$193.00K
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$36.00K
10-Q · filed 2015-08-12
$112.00K
10-Q · filed 2015-08-12
$148.00K
derived: sum of 3 quarters · filed 2015-08-12
$184.00K
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31$76.00K
10-Q · filed 2015-05-12
$112.00K
derived: sum of 2 quarters · filed 2015-05-12
$148.00K
derived: sum of 3 quarters · filed 2015-05-12
$184.00K
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31$36.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$72.00K
derived: sum of 2 quarters · filed 2015-03-19
$108.00K
derived: sum of 3 quarters · filed 2015-03-19
$150.00K
10-K · filed 2015-03-19
2013-09-30$36.00K
10-Q · filed 2014-11-07
$72.00K
derived: sum of 2 quarters · filed 2014-11-07
$114.00K
10-Q · filed 2014-11-07
$167.00K
derived: sum of 4 quarters · filed 2015-03-19
2013-06-30$36.00K
10-Q · filed 2014-08-08
$78.00K
10-Q · filed 2014-08-08
$131.00K
derived: sum of 3 quarters · filed 2015-03-19
$170.00K
derived: sum of 4 quarters · filed 2015-03-19
2013-03-31$42.00K
10-Q · filed 2014-05-09
$95.00K
derived: sum of 2 quarters · filed 2015-03-19
$134.00K
derived: sum of 3 quarters · filed 2015-03-19
$183.00K
derived: sum of 4 quarters · filed 2015-03-19
2012-12-31$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
$92.00K
derived: sum of 2 quarters · filed 2015-03-19
$141.00K
derived: sum of 3 quarters · filed 2015-03-19
$213.00K
10-K · filed 2015-03-19
2012-09-30$39.00K
10-Q · filed 2013-11-08
$88.00K
derived: sum of 2 quarters · filed 2013-11-08
$160.00K
10-Q · filed 2013-11-08
$198.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$49.00K
10-Q · filed 2013-08-09
$121.00K
10-Q · filed 2013-08-09
$159.00K
derived: sum of 3 quarters · filed 2014-03-14
$204.00K
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$72.00K
10-Q · filed 2013-05-08
$110.00K
derived: sum of 2 quarters · filed 2014-03-14
$155.00K
derived: sum of 3 quarters · filed 2014-03-14
$191.00K
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$38.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
$83.00K
derived: sum of 2 quarters · filed 2014-03-14
$119.00K
derived: sum of 3 quarters · filed 2014-03-14
$161.00K
10-K · filed 2014-03-14
2011-09-30$45.00K
10-Q · filed 2012-11-02
$81.00K
derived: sum of 2 quarters · filed 2012-11-02
$123.00K
10-Q · filed 2012-11-02
$150.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$36.00K
10-Q · filed 2012-08-08
$78.00K
10-Q · filed 2012-08-08
$105.00K
derived: sum of 3 quarters · filed 2013-03-18
$140.00K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$42.00K
10-Q · filed 2012-05-07
$69.00K
derived: sum of 2 quarters · filed 2013-03-18
$104.00K
derived: sum of 3 quarters · filed 2013-03-18
$145.00K
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$27.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$62.00K
derived: sum of 2 quarters · filed 2013-03-18
$103.00K
derived: sum of 3 quarters · filed 2013-03-18
$135.00K
10-K · filed 2013-03-18
2010-09-30$35.00K
10-Q · filed 2011-11-09
$76.00K
derived: sum of 2 quarters · filed 2011-11-09
$108.00K
10-Q · filed 2011-11-09
2010-06-30$41.00K
10-Q · filed 2011-08-05
$73.00K
10-Q · filed 2011-08-05
2009-12-31$111.00K
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B